Kraš prehrambena industrija d.d. financials
Kraš prehrambena industrija d.d.
74780000N00HZTWVU688 | Line item | 2022 | 2021 |
|---|---|---|
| Income statement | ||
| Cost of sales | HRK 17.9M | HRK 11.7M |
| Other income | HRK 25.3M | HRK 17.4M |
| Employee benefits expense | HRK 250.6M | HRK 240.1M |
| Raw materials & consumables used | HRK 601.8M | HRK 510.3M |
| Depreciation & amortisation | HRK 62.4M | HRK 56.5M |
| Finance costs | HRK 9.1M | HRK 8.9M |
| Profit before tax | HRK 44.8M | HRK 38.4M |
| Income tax expense | HRK 8.4M | HRK 8.3M |
| Profit for the year | HRK 36.4M | HRK 30.1M |
| — attributable to owners | HRK 36.4M | HRK 30.1M |
| — attributable to NCI | HRK 0 | HRK 3.0K |
| Total comprehensive income | HRK 36.0M | HRK 30.4M |
| Per share | ||
| Basic EPS | HRK 25.66 | HRK 21.23 |
| Free cash flow / share | HRK -13.79 | HRK 15.09 |
| Cash flow statement | ||
| Cash generated from operations | HRK 45.8M | HRK 97.8M |
| Net cash from operating activities | HRK 35.1M | HRK 91.5M |
| Net cash from investing activities | -HRK 60.2M | -HRK 72.6M |
| Purchase of PP&E (capex) | HRK 54.7M | HRK 70.1M |
| Purchase of intangibles | HRK 5.8M | HRK 2.4M |
| Net cash from financing activities | HRK 98.8M | -HRK 8.8M |
| Dividends paid | HRK 14.2M | HRK 0 |
| Proceeds from borrowings | HRK 188.4M | HRK 79.8M |
| Repayments of borrowings | HRK 70.0M | HRK 84.5M |
| Lease liability payments | HRK 5.5M | HRK 4.1M |
| Balance sheet | ||
| Total assets | HRK 1.25B | HRK 1.09B |
| Non-current assets | HRK 603.6M | HRK 615.6M |
| Property, plant & equipment | HRK 507.0M | HRK 517.3M |
| Right-of-use assets | HRK 13.6M | HRK 19.7M |
| Current assets | HRK 644.8M | HRK 474.2M |
| Inventories | HRK 250.0M | HRK 177.5M |
| Trade & other receivables | HRK 254.2M | HRK 230.7M |
| Cash & equivalents | HRK 125.1M | HRK 51.4M |
| Total equity | HRK 773.5M | HRK 751.5M |
| — attributable to owners | HRK 773.5M | HRK 751.2M |
| Non-controlling interests | HRK 0 | HRK 236.0K |
| Non-current liabilities | HRK 243.9M | HRK 120.2M |
| Lease liabilities (non-current) | HRK 10.6M | HRK 15.5M |
| Current liabilities | HRK 231.0M | HRK 218.1M |
| Lease liabilities (current) | HRK 3.9M | HRK 5.5M |
| Deferred tax liabilities | HRK 9.4M | HRK 9.6M |
| Derived metrics | ||
| Free cash flow | -HRK 19.6M | HRK 21.4M |
| Net margin | 3.2% | 2.9% |
| Return on equity | 4.7% | 4.0% |
| Cash conversion ratio | 0.96× | 3.04× |
| Capex coverage | 0.64× | 1.31× |
| Other reported items | ||
| Adjustments For Decrease Increase In Inventories | -HRK 75.1M | -HRK 40.8M |
| Adjustments For Decrease Increase In Trade and Other Receivables | -HRK 44.4M | -HRK 4.3M |
| Adjustments For Depreciation and Amortisation Expense | HRK 62.4M | HRK 56.5M |
| Adjustments For Gains Losses On Fair Value Adjustment Investment Property | -HRK 986.0K | -HRK 4.0M |
| Adjustments For Impairment Loss Reversal of Impairment Loss Recognised In Profit Or Loss Inventories | HRK 2.6M | HRK 3.6M |
| Adjustments For Impairment Loss Reversal of Impairment Loss Recognised In Profit Or Loss Trade and Other Receivables | HRK 20.0M | HRK 18.0M |
| Adjustments For Increase Decrease In Trade and Other Payables | HRK 666.0K | -HRK 1.7M |
| Adjustments For Interest Expense | HRK 1.0M | HRK 1.1M |
| Adjustments For Interest Income | HRK 13.0K | HRK 12.0K |
| Adjustments For Provisions | HRK 26.9M | HRK 3.1M |
| Capital Redemption Reserve | HRK 40.2M | HRK 40.2M |
| Capital Reserve | -HRK 15.4M | -HRK 15.4M |
| Cash Flows From Used In Operations Before Changes In Working Capital | HRK 164.8M | HRK 144.5M |
| Changes In Inventories of Finished Goods and Work In Progress | -HRK 35.6M | HRK 918.0K |
| Comprehensive Income Attributable To Noncontrolling Interests | HRK 0 | HRK 3.0K |
| Comprehensive Income Attributable To Owners of Parent | HRK 36.0M | HRK 30.4M |
| Current Financial Assets At Amortised Cost | HRK 27.0K | HRK 15.0K |
| Current Loans Received and Current Portion of Noncurrent Loans Received | HRK 73.7M | HRK 58.5M |
| Current Tax Liabilities Current | HRK 7.0M | HRK 8.5M |
| Deferred Tax Assets | HRK 3.2M | HRK 4.2M |
| Dividends Received Classified As Investing Activities | HRK 2.0K | HRK 0 |
| Equity and Liabilities | HRK 1.25B | HRK 1.09B |
| Finance Income | HRK 9.7M | HRK 8.9M |
| Gains Losses On Exchange Differences On Translation Net of Tax | HRK 59.0K | -HRK 442.0K |
| Impairment Loss Impairment Gain and Reversal of Impairment Loss Determined In Accordance With IFRS9 | HRK 3.9M | HRK 9.9M |
| Impairment Loss Reversal of Impairment Loss Recognised In Profit Or Loss | HRK 2.8M | HRK 3.6M |
| Income Taxes Paid Refund Classified As Operating Activities | HRK 9.6M | HRK 5.1M |
| Increase Decrease In Cash and Cash Equivalents | HRK 73.7M | HRK 10.1M |
| Increase Decrease Through Change In Equity of Subsidiaries | -HRK 438.0K | -HRK 3.2M |
| Increase Decrease Through Transfer To Statutory Reserve | — | HRK 0 |
| Increase Decrease Through Transfers and Other Changes Equity | HRK 615.0K | — |
| Intangible Assets Other Than Goodwill | HRK 8.1M | HRK 3.6M |
| Interest Paid Classified As Operating Activities | HRK 1.1M | HRK 1.1M |
| Interest Received Classified As Investing Activities | HRK 12.0K | HRK 12.0K |
| Investment Property | HRK 60.8M | HRK 58.7M |
| Issued Capital | HRK 599.4M | HRK 599.4M |
| Liabilities | HRK 475.0M | HRK 338.2M |
| Miscellaneous Other Operating Expense | HRK 859.0K | HRK 1.1M |
| Noncurrent Biological Assets | HRK 756.0K | HRK 813.0K |
| Noncurrent Financial Assets At Amortised Cost | HRK 366.0K | HRK 638.0K |
| Noncurrent Investments In Equity Instruments Designated At Fair Value Through Other Comprehensive Income | HRK 9.3M | HRK 9.9M |
| Noncurrent Investments Other Than Investments Accounted For Using Equity Method | HRK 0 | HRK 0 |
| Noncurrent Payables To Trade Suppliers | HRK 109.8M | HRK 112.1M |
| Noncurrent Portion of Noncurrent Loans Received | HRK 177.0M | HRK 73.8M |
| Noncurrent Provisions | HRK 46.7M | HRK 19.8M |
| Other Adjustments For Noncash Items | HRK 6.0M | HRK 19.8M |
| Other Cash Payments To Acquire Equity Or Debt Instruments of Other Entities Classified As Investing Activities | HRK 236.0K | HRK 2.7M |
| Other Comprehensive Income | -HRK 401.0K | HRK 251.0K |
| Other Comprehensive Income Net of Tax Gains Losses From Investments In Equity Instruments | -HRK 459.0K | HRK 692.0K |
| Other Current Financial Assets | HRK 88.0K | HRK 90.0K |
| Other Current Financial Liabilities | HRK 276.0K | HRK 308.0K |
| Other Current Nonfinancial Liabilities | HRK 36.5M | HRK 33.2M |
| Other Current Receivables | HRK 15.4M | HRK 14.4M |
| Other Expense By Nature | HRK 92.9M | HRK 75.3M |
| Other Inflows Outflows of Cash Classified As Financing Activities | HRK 43.0K | HRK 0 |
| Other Inflows Outflows of Cash Classified As Investing Activities | HRK 261.0K | HRK 605.0K |
| Other Noncurrent Financial Assets | HRK 473.0K | HRK 712.0K |
| Other Noncurrent Financial Liabilities | HRK 126.0K | HRK 1.3M |
| Other Noncurrent Nonfinancial Liabilities | HRK 185.0K | HRK 332.0K |
| Other Reserves | -HRK 2.8M | -HRK 3.0M |
| Purchase of Investment Property | HRK 0 | HRK 189.0K |
| Purchase of Treasury Shares | HRK 0 | — |
| Reserve of Exchange Differences On Translation | -HRK 3.1M | -HRK 3.2M |
| Retained Earnings | HRK 149.8M | HRK 127.4M |
| Revenue From Contracts With Customers | HRK 1.14B | HRK 1.05B |
| Services Expense | HRK 124.9M | HRK 118.2M |
| Statutory Reserve | HRK 32.4M | HRK 32.4M |
| Treasury Shares | HRK 40.2M | HRK 40.2M |
Every line item above is a fact tagged in Kraš prehrambena industrija d.d.'s annual report
filed in the European Single Electronic Format (ESEF) under the IFRS
taxonomy (ifrs-full) — the income statement, balance sheet
and cash-flow statement as the filer reported them. Values are shown
as-is, in the reporting currency (HRK), without
rescaling; the row labels map to the underlying concept name (e.g.
Revenue → ifrs-full:Revenue, Operating profit →
ifrs-full:ProfitLossFromOperatingActivities, Diluted EPS →
ifrs-full:DilutedEarningsLossPerShare), and any concept
without a curated label is shown under “Other reported items” with its
de-camel-cased tag name. Only consolidated, default-member facts are
shown (segment / dimensional breakdowns are excluded).
“Derived metrics” (free cash flow, margins, ROE, …) are computed from those facts by the same model the U.S. financials pages use — not tagged by the filer.
Source: machine-readable OIM xBRL-JSON aggregated by filings.xbrl.org (XBRL International). Entity identity is resolved by LEI via the public-domain GLEIF register. This is reference data, not investment advice.